• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o DNA extraction - Market size and forecast 2019-2024 o RNA extraction - Market size and forecast 2019-2024 o Market opportunity by Product • Customer Landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o Asia - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Market drivers o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Agilent Technologies Inc. o Beckman Coulter Inc. o bioMérieux SA o Bio-Rad Laboratories Inc. o Cytiva o F. Hoffmann-La Roche Ltd. o Merck KGaA o PerkinElmer Inc. o Promega Corp. o Thermo Fisher Scientific Inc. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ million) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Product - Market share 2019-2024 (%) • 22: Comparison by Product • 23: DNA extraction - Market size and forecast 2019-2024 ($ million) • 24: DNA extraction - Year-over-year growth 2019-2024 (%) • 25: RNA extraction - Market size and forecast 2019-2024 ($ million) • 26: RNA extraction - Year-over-year growth 2019-2024 (%) • 27: Market opportunity by Product • 28: Customer landscape • 29: Market share by geography 2019-2024 (%) • 30: Geographic comparison • 31: North America - Market size and forecast 2019-2024 ($ million) • 32: North America - Year-over-year growth 2019-2024 (%) • 33: Europe - Market size and forecast 2019-2024 ($ million) • 34: Europe - Year-over-year growth 2019-2024 (%) • 35: Asia - Market size and forecast 2019-2024 ($ million) • 36: Asia - Year-over-year growth 2019-2024 (%) • 37: ROW - Market size and forecast 2019-2024 ($ million) • 38: ROW - Year-over-year growth 2019-2024 (%) • 39: Key leading countries • 40: Market opportunity by geography ($ million) • 41: Impact of drivers and challenges • 42: Vendor landscape • 43: Landscape disruption • 44: Industry risks • 45: Vendors covered • 46: Market positioning of vendors • 47: Agilent Technologies Inc. - Overview • 48: Agilent Technologies Inc. - Business segments • 49: Agilent Technologies Inc. - Key offerings • 50: Agilent Technologies Inc. - Key customers • 51: Agilent Technologies Inc. - Segment focus • 52: Beckman Coulter Inc. - Overview • 53: Beckman Coulter Inc. - Product and service • 54: Beckman Coulter Inc. - Key offerings • 55: Beckman Coulter Inc. - Key customers • 56: Beckman Coulter Inc. - Segment focus • 57: bioMérieux SA - Overview • 58: bioMérieux SA - Business segments • 59: bioMérieux SA - Key offerings • 60: bioMérieux SA - Key customers • 61: bioMérieux SA - Segment focus • 62: Bio-Rad Laboratories Inc. - Overview • 63: Bio-Rad Laboratories Inc. - Business segments • 64: Bio-Rad Laboratories Inc. - Key offerings • 65: Bio-Rad Laboratories Inc. - Key customers • 66: Bio-Rad Laboratories Inc. - Segment focus • 67: Cytiva - Overview • 68: Cytiva - Product and service • 69: Cytiva - Key offerings • 70: Cytiva - Key customers • 71: Cytiva - Segment focus • 72: F. Hoffmann-La Roche Ltd. - Overview • 73: F. Hoffmann-La Roche Ltd. - Product and service • 74: F. Hoffmann-La Roche Ltd. - Key offerings • 75: F. Hoffmann-La Roche Ltd. - Key customers • 76: F. Hoffmann-La Roche Ltd. - Segment focus • 77: Merck KGaA - Overview • 78: Merck KGaA - Business segments • 79: Merck KGaA - Key offerings • 80: Merck KGaA - Key customers • 81: Merck KGaA - Segment focus • 82: PerkinElmer Inc. - Overview • 83: PerkinElmer Inc. - Business segments • 84: PerkinElmer Inc. - Key offerings • 85: PerkinElmer Inc. - Key customers • 86: PerkinElmer Inc. - Segment focus • 87: Promega Corp. - Overview • 88: Promega Corp. - Product and service • 89: Promega Corp. - Key offerings • 90: Promega Corp. - Key customers • 91: Promega Corp. - Segment focus • 92: Thermo Fisher Scientific Inc. - Overview • 93: Thermo Fisher Scientific Inc. - Business segments • 94: Thermo Fisher Scientific Inc. - Key offerings • 95: Thermo Fisher Scientific Inc. - Key customers • 96: Thermo Fisher Scientific Inc. - Segment focus • 97: Currency conversion rates for US$ • 98: Research Methodology • 99: Validation techniques employed for market sizing • 100: Information sources • 101: List of abbreviations

Agilent Technologies Inc., Beckman Coulter Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cytiva, F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., Promega Corp., Thermo Fisher Scientific Inc.